---
figid: PMC3837566__nihms377464f1
figlink: /pmc/articles/PMC3837566/figure/F1/
number: F1
caption: A. BRAFV600E promotes tumor growth through hyperactivation of the MEK-ERK
  pathway. Treatment with BRAF inhibitors (BRAFi) such as PLX4032 blocks this signaling
  pathway, leading to tumor shrinkage. B. When cells bearing BRAFWT are treated with
  BRAF inhibitors, a BRAF/CRAF heterodimerization induces activation of the MEK-ERK
  pathway. This results in increased cell proliferation, which may contribute to the
  development of squamous cell carcinoma (SCC).
pmcid: PMC3837566
papertitle: 'Targeted inhibition of BRAF kinase: opportunities and challenges for
  therapeutics in melanoma.'
reftext: Rolando PÃ©rez-Lorenzo, et al. Biosci Rep. ;32(1):10.1042/BSR20110068.
pmc_ranked_result_index: '69321'
pathway_score: 0.9125021
filename: nihms377464f1.jpg
figtitle: 'Targeted inhibition of BRAF kinase: opportunities and challenges for therapeutics
  in melanoma'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3837566__nihms377464f1.html
  '@type': Dataset
  description: A. BRAFV600E promotes tumor growth through hyperactivation of the MEK-ERK
    pathway. Treatment with BRAF inhibitors (BRAFi) such as PLX4032 blocks this signaling
    pathway, leading to tumor shrinkage. B. When cells bearing BRAFWT are treated
    with BRAF inhibitors, a BRAF/CRAF heterodimerization induces activation of the
    MEK-ERK pathway. This results in increased cell proliferation, which may contribute
    to the development of squamous cell carcinoma (SCC).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - KRAS
  - HRAS
  - MAP2K2
  - NRAS
  - MAPK1
  - MAP2K1
  - RAF1
  - MAPK3
genes:
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: WI/RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: WI/RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: WI/RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals: []
diseases: []
figid_alias: PMC3837566__F1
redirect_from: /figures/PMC3837566__F1
figtype: Figure
---
